Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$739,086
+$8,998 QoQ
Shares Held
2,041
-1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,916
of 3,140 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Signal Advisors Wealth, LLC holds $29,778,924 across 9 Drug Manufacturers - General names. AMGN ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,191 | $13,422,822 | |
| 2 | JNJ |
Johnson & Johnson
|
23,993 | $6,093,502 | |
| 3 | ABBV |
AbbVie Inc.
|
22,938 | $5,772,118 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,779 | $2,156,101 | |
| 5 | AMGN |
Amgen Inc
This page
|
2,041 | $739,086 | |
| 6 | AZN |
Astrazeneca PLC
|
2,706 | $513,111 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,813 | $450,185 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,752 | $347,687 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $739,086 | 2,041 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $730,088 | 2,075 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $747,248 | 2,283 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $867,482 | 3,074 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,759,023 | 6,300 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $582,286 | 1,869 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $490,263 | 1,881 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $544,857 | 1,691 | Shares | Sole | 2024-10-15 | |
| No filing history on record for this holder in this stock. | ||||||